ARCHIVES

Watson To Head Genome Research

This article is from The Cancer Letter archive.

Vol. 14 No. 38 | September 30, 1988

Download PDF Visit The Full Archive

Related Articles

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

January 6, 1989

Public Participation Hearings Develop Gals for Reducing Cancer Mortality

February 17, 1989

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

October 31, 2014

NCI To Proceed With Guidelines Unless Board Strongly Disagree

May 9, 1980

AACI Resolution Asks Congress To Support 1991 Bypass Budget

July 13, 1990

ASCO President Criticizes Use Of Cooperative Agreement in Clinical Trials

May 18, 1984